Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Intelligencia AI
What AI says about Intelligencia AI
Intelligencia AI specializes in de-risking clinical development through AI-driven solutions tailored for the pharmaceutical industry. Their innovative platform enhances decision-making by providing accurate assessments of drug success probabilities and streamlining the drug development process.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Products & Services
Intelligencia Portfolio Optimizer
A patented SaaS platform that provides on-demand access to AI-powered insights for assessing the probability of success and phase transition probabilities in drug development.
Dynamic Benchmarks
A service that offers comprehensive historical approval and failure rates to enhance risk assessment and strategy for drug development.
Data & Insights
A service that leverages meticulously curated and harmonized data for customized analyses to support drug development strategies.
Common Questions
What does Intelligencia AI do?
Intelligencia AI provides AI-driven solutions to de-risk clinical development and enhance decision-making in the pharmaceutical industry.
What is the Intelligencia Portfolio Optimizer?
The Intelligencia Portfolio Optimizer is a patented SaaS platform that delivers AI-powered insights for assessing drug success probabilities.
How does Intelligencia AI help in drug development?
Intelligencia AI helps organizations by providing accurate assessments of drug success probabilities and streamlining the drug development process using AI.
When was Intelligencia AI founded?
Intelligencia AI was founded in 2017.
Who are Intelligencia AI's clients?
Intelligencia AI works with leading pharmaceutical organizations to enhance their clinical development and business strategies.